In summary, considering the MetS as a complex condition encompassing obesity, hypertension, and diabetes mellitus, it is plausible that a significant decrease in KLK1 may manifest in patients with the MetS. This evidence concerns the gene KLK1 and obesity due to melanocortin 4 receptor deficiency.